Creality brings a striking line-up of high-speed 3D printer flagships to Chicago's McCormick Place from May 2 to 4 for RAPID + TCT 2023, the largest and most influential additive manufacturing...

- Oral presentations highlight efficacy and safety outcomes from the upadacitinib (RINVOQ®) clinical trial program in adults with moderately to severely active Crohn's disease, and...

– IMU-856 is an Orally Available, Systemically Acting, Highly Selective and Potent Small Molecule Modulator of SIRT6 – – Targets Regeneration of Bowel Epithelium and Restoration of...

Oak Point University, an academic leader that has prepared students for successful careers as nurses and nurse leaders for more than 100 years, launches its second annual "Built to Be a Nurse"...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company...